Modulation of blood flow, hypoxia, and vascular function in orthotopic prostate tumors during exercise

Journal of the National Cancer Institute

Volumn 106, Issue 4, 2014, Pages

  McCullough, Danielle J ^a   Stabley, John N ^a   Siemann, Dietmar W ^b,c   Behnke, Bradley J ^a,c  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COBALT 57; STRONTIUM 85; VASOCONSTRICTOR AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; NORADRENALIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIOLE; ARTICLE; BLOOD VESSEL; CANCER RESISTANCE; CANCER VASCULATURE; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; COPENHAGEN RAT; EXERCISE; HYPOXIA; IN VITRO STUDY; MALE; MEASUREMENT; MODULATION; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; OXYGENATION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE VENTRAL LOBE; RAT; TREADMILL EXERCISE; TUMOR BLOOD FLOW; TUMOR MICROENVIRONMENT; VASCULAR RESISTANCE; VASOCONSTRICTION; ANIMAL; CELL HYPOXIA; DOSE RESPONSE; DRUG EFFECT; INBRED RAT STRAIN; PROSTATE TUMOR; RANDOMIZATION; VASCULARIZATION;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; CELL HYPOXIA; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; NOREPINEPHRINE; PHYSICAL EXERTION; PROSTATIC NEOPLASMS; RANDOM ALLOCATION; RATS; RATS, INBRED STRAINS; VASCULAR RESISTANCE; VASOCONSTRICTOR AGENTS;

EID: 84898926809     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/dju036     Document Type: Article

References (56)

1. Mereles D, Ehlken N, Kreuscher S, et al. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation. 2006;114(14):1482-1489.
2. National Cancer Institute. Physical Activity and Cancer. http://www.cancer. gov/cancertopics/factsheet/prevention/physicalactivity. Accessed February 12, 2014.
3. Rock CL, Doyle C, Demark-Wahnefried W, et al. Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin. 2012;62(4):243-274.
4. Musch TI, Friedman DB, Pitetti KH, et al. Regional distribution of blood flow of dogs during graded dynamic exercise. J Appl Physiol. 1987;63(6):2269-2277.
5. Rowell L. Human Cardiovascular Control. Oxford: Oxford University Press; 1993.
6. Jones LW, Viglianti BL, Tashjian JA, et al. Effect of aerobic exercise on tumor physiology in an animal model of human breast cancer. J Appl Physiol. 2010;108(2):343-348.
7. Vaupel P. Hypoxia and aggressive tumor phenotype: implications for therapy and prognosis. Oncologist. 2008;13(Suppl 3):21-26.
8. Woods JA, Davis JM, Kohut ML, et al. Effects of exercise on the immune response to cancer. Med Sci Sports Exerc. 1994;26(9):1109-1115.
9. Cohen LA, Boylan E, Epstein M, et al. Voluntary exercise and experimental mammary cancer. Adv Exp Med Biol. 1992;322:41-59.
10. Thompson HJ, Westerlind KC, Snedden JR, et al. Inhibition of mammary carcinogenesis by treadmill exercise. J Natl Cancer Inst. 1995;87(6):453-455.
11. Westerlind KC, McCarty HL, Schultheiss PC, et al. Moderate exercise training slows mammary tumour growth in adolescent rats. Eur J Cancer Prev. 2003;12(4):281-287.
12. Menke H, Vaupel P. Effect of injectable or inhalational anesthetics and of neuroleptic, neuroleptanalgesic, and sedative agents on tumor blood flow. Radiat Res. 1988;114(1):64-76.
13. Lubaroff DM, Canfield L, Feldbush TL, et al. R3327 adenocarcinoma of the Copenhagen rat as a model for the study of the immunologic aspects of prostate cancer. J Natl Cancer Inst. 1977;58(6):1677-1689.
14. National Institutes of Health. Guide for the Care and Use of Laboratory Animals. Washington, DC: National Research Council; 1995.
15. Dunning WF. Prostate cancer in the rat. Natl Cancer Inst Monogr 1963;12:351-369.
16. Kiessling F, Huber PE, Grobholz R, et al. Dynamic magnetic resonance tomography and proton magnetic resonance spectroscopy of prostate cancers in rats treated by radiotherapy. Invest Radiol. 2004;39(1):34-44.
17. Isaacs JT, Heston WD, Weissman RM, et al. Animal models of the hormone-sensitive and-insensitive prostatic adenocarcinomas, Dunning R-3327-H, R-3327-HI, and R-3327-AT. Cancer Res. 1978;38(11 Pt 2):4353-4359.
18. Behnke BJ, Prisby RD, Lesniewski LA, et al. Influence of ageing and physical activity on vascular morphology in rat skeletal muscle. J Physiol. 2006;575(Pt 2):617-626.
19. Davis RT 3rd, Stabley JN, Dominguez JM 2nd, et al. Differential effects of aging and exercise on intra-abdominal adipose arteriolar function and blood flow regulation. J Appl Physiol. 2013;114(6):808-815.
20. McCullough DJ, Davis RT 3rd, Dominguez JM 2nd, et al. Effects of aging and exercise training on spinotrapezius muscle microvascular PO2 dynamics and vasomotor control. J Appl Physiol. 2011;110(3):695-704.
21. Laughlin MH, Armstrong RB. Rat muscle blood flows as a function of time during prolonged slow treadmill exercise. Am J Physiol. 1983;244(6):H814-H824.
22. Ishise S, Pegram BL, Yamamoto J, et al. Reference sample microsphere method: cardiac output and blood flows in conscious rat. Am J Physiol. 1980;239(4):H443-H449.
23. Behnke BJ, McDonough P, Padilla DJ, et al. Oxygen exchange profile in rat muscles of contrasting fibre types. J Physiol. 2003;549(Pt 2):597-605.
24. Smith KA, Hill SA, Begg AC, et al. Validation of the fluorescent dye Hoechst 33342 as a vascular space marker in tumours. Br J Cancer. 1988;57(3):247-253.
25. Salmon HW, Siemann DW. Effect of the second-generation vascular disrupting agent OXi4503 on tumor vascularity. Clin Cancer Res. 2006;12(13):4090-4094.
26. Siemann DW, Rojiani AM. The vascular disrupting agent ZD6126 shows increased antitumor efficacy and enhanced radiation response in large, advanced tumors. Int J Radiat Oncol Biol Phys. 2005;62(3):846-853.
27. Koch CJ, Hahn SM, Rockwell K Jr, et al. Pharmacokinetics of EF5 [2-(2-nitro-1-H-imidazol-1-yl)-N-(2, 2, 3, 3, 3-pentafluoropropyl) acetamide] in human patients: implications for hypoxia measurements in vivo by 2-nitroimidazoles. Cancer Chemother Pharmacol. 2001;48(3):177-187.
28. Yuan H, Schroeder T, Bowsher JE, et al. Intertumoral differences in hypoxia selectivity of the PET imaging agent 64Cu(II)-diacetyl-bis(N4- methylthiosemicarbazone). J Nucl Med. 2006;47(6):989-998.
29. Behnke BJ, Ramsey MW, Stabley JN, et al. Effects of aging and exercise training on skeletal muscle blood flow and resistance artery morphology. J Appl Physiol. 2012;113(11):1699-1708.
30. Steiner JL, Davis JM, McClellan JL, et al. Effects of voluntary exercise on tumorigenesis in the C3(1)/SV40Tag transgenic mouse model of breast cancer. Int J Oncol. 2013;42(4):1466-1472.
31. Hockel M, Vaupel P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst. 2001;93(4):266-276.
32. Wilson WR, Hay M P. Targeting hypoxia in cancer therapy. Nat Rev Cancer. 2011;11(6):393-410.
33. Brahimi-Horn MC, Chiche J, Pouyssegur J. Hypoxia and cancer. J Mol Med (Berl). 2007;85(12):1301-1307.
34. 2 availability on human cancer. Nat Rev Cancer. 2008;8(12):967-975.
35. Saltin B, Radegran G, Koskolou MD, et al. Skeletal muscle blood flow in humans and its regulation during exercise. Acta Physiol Scand. 1998;162(3):421-436.
36. Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res. 1989;49(23):6449-6465.
37. Secomb TW, Hsu R, Ong ET, et al. Analysis of the effects of oxygen supply and demand on hypoxic fraction in tumors. Acta Oncol. 1995;34(3):313-316.
38. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324(5930):1029-1033.
39. Vaupel P, Harrison L. Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response. Oncologist 2004;9(Suppl 5):4-9.
40. De Jaeger K, Kavanagh MC, Hill R P. Relationship of hypoxia to metastatic ability in rodent tumours. Br J Cancer. 2001;84(9):1280-1285.
41. Vaupel P, Briest S, Hockel M. Hypoxia in breast cancer: pathogenesis, characterization and biological/therapeutic implications. Wien Med Wochenschr. 2002;152(13-14):334-342.
42. Zheng X, Cui XX, Huang MT, et al. Inhibition of progression of androgen-dependent prostate LNCaP tumors to androgen independence in SCID mice by oral caffeine and voluntary exercise. Nutr Cancer. 2012;64(7):1029-1037.
43. Colbert LH, Westerlind KC, Perkins SN, et al. Exercise effects on tumo-rigenesis in a p53-deficient mouse model of breast cancer. Med Sci Sports Exerc. 2009;41(8):1597-1605.
44. Kenfield SA, Stampfer MJ, Giovannucci E, et al. Physical activity and survival after prostate cancer diagnosis in the health professionals follow-up study. J Clin Oncol. 2011;29(6):726-732.
45. McCullough DJ, Nguyen LM, Siemann DW, et al. Effects of exercise training on tumor hypoxia and vascular function in the rodent preclinical ortho-topic prostate cancer model. J Appl Physiol (1985). 2013;115(12):1846-1854.
46. Lim CS, Qiao X, Reslan OM, et al. Prolonged mechanical stretch is associated with upregulation of hypoxia-inducible factors and reduced contraction in rat inferior vena cava. J Vasc Surg. 2011;53(3):764-773.
47. Chang H, Shyu KG, Wang BW, et al. Regulation of hypoxia-inducible factor-1alpha by cyclical mechanical stretch in rat vascular smooth muscle cells. Clin Sci (Lond). 2003;105(4):447-456.
48. Rowell LB. Human cardiovascular adjustments to exercise and thermal stress. Physiol Rev. 1974;54(1):75-159.
49. Magnon C, Hall SJ, Lin J, et al. Autonomic nerve development contributes to prostate cancer progression. Science. 2013;341(6142):1236361.
50. Verma VK, Singh V, Singh MP, et al. Effect of physical exercise on tumor growth regulating factors of tumor microenvironment: implications in exercise-dependent tumor growth retardation. Immunopharmacol Immunotoxicol. 2009;31(2):274-282.
51. MacNeil B, Hoffman-Goetz L. Exercise training and tumour metastasis in mice: influence of time of exercise onset. Anticancer Res. 1993;13(6A):2085- 2088.
52. Hudlicka O, Brown M, Egginton S. Angiogenesis in skeletal and cardiac muscle. Physiol Rev. 1992;72(2):369-417.
53. Jones LW, Antonelli J, Masko EM, et al. Exercise modulation of the host-tumor interaction in an orthotopic model of murine prostate cancer. J Appl Physiol. 2012;113(2):263-272.
54. 2 dependent control of metabolism. Med Sci Sports Exerc. 1995;27(1):47-53.
55. Goliasova T, denko NC. Hypoxia-inducible factor 1 (HIF1) mediated adaptive responses in the solid tumor. In: Siemann DW, ed. Tumor Microenvironment. Chichester, West Sussex, UK: John Wiley & Sons; 2011:271-290.
56. Kallinowski F, Schlenger KH, Runkel S, et al. Blood flow, metabolism, cellular microenvironment, and growth rate of human tumor xenografts. Cancer Res. 1989;49(14):3759-3764.